Cargando…
Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014
Cachexia is a serious but underrecognised consequence of many chronic diseases. Its prevalence ranges from 5–15 % in end-stage chronic heart failure to 50–80 % in advanced cancer. Cachexia is also part of the terminal course of many patients with chronic kidney disease, chronic obstructive pulmonary...
Autores principales: | von Haehling, Stephan, Anker, Stefan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248411/ https://www.ncbi.nlm.nih.gov/pubmed/25384990 http://dx.doi.org/10.1007/s13539-014-0164-8 |
Ejemplares similares
-
Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014
por: Morley, John E., et al.
Publicado: (2014) -
Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact
por: Konishi, Masaaki, et al.
Publicado: (2016) -
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016
por: von Haehling, Stephan, et al.
Publicado: (2016) -
Cachexia as a major underestimated and unmet medical need: facts and numbers
por: von Haehling, Stephan, et al.
Publicado: (2010) -
Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers
por: Anker, Markus S., et al.
Publicado: (2020)